Subject: CNAB Enjoys Healthy Run this Week Stock Up Over 70% Since Monday

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
After an amazing rally this week shares of CNAB have pulled back from possible shorts and natural profit taking. GOOD NEWS is a floor appears to be found at 1.25 and at the time of this email shares were trading at 1.45! All in all a very healthy week following the big news last week. Read about it below.

United Cannabis Corp.
Suite 200-883
9249 South Broadway
Highlands Ranch, CO 80129
Phone: (303) 904-9296
Facebook Twitter

United Cannabis Corporation Signs Licensing Agreement for California with Foxbarry Farms Tribal Development Group


United Cannabis Corporation is a bio cannabinoid technologies company built on scientific research, product development, and implementation of its unique proprietary cannabinoid therapy program. United Cannabis Corporation has a solid foundation in the cannabis industry, but more importantly we have benefited from the thousands of faces, stories, and lives we have come into contact with through our programs and experiences over the years. With our consulting services, management and oversight we are capable of assisting any Cannabis oriented company on any scale. United Cannabis Corporation is now partnering domestically and internationally with local businessmen, entrepreneurs, and scientists for the purpose of promoting Best Practices in Planning, Procedures, Governance and Patient Care. With access to a prolific catalog of award winning genetics (including over 15 unique CBD dominant strains) and coupled with our leadership & experience we are positioned to take any Cannabis Business through all of the steps for immediate success.

Value Proposition:

Strong Alliances: Recently announced collaboration of United Cannabis’s A.C.T. Now Program with a leading physicians electronic health record provider to release a physician’s software edition. This streamlines a complex problem for physicians in the MMJ space. Now physicians in legal medical states will be able to utilize this software to recommend certified company products, with dosing guidelines, to patients seeking cannabis based products for chronic disease and various forms of cancer.

More about A.C.T. (Advanced Cannabinoid Therapy) Program: A.C.T. Now utilizes a fully integrated modern cloud-based EHR & Practice Management software designed for physicians seeking full spectrum cannabinoid based products with: dosing recommendations, charting, billing, records, e-prescribing, lab results, scheduling, program cost analysis, and patient portals meeting FDA clinical standards. Learn more here.

CNAB has multiple and diversified revenue streams;
  • Licensing fees paid for intellectual property and management services
  • Brokerage fees to United Cannabis Corp. by contracted affiliates
  • Licensing fees paid for individual product lines
  • Direct ownership of cultivation and dispensary facilities where it is federally legal
Massive Market: CNAB works with clients of all size including local businessmen, entrepreneurs, and scientists as well as large companies. United Cannabis will provide the science and methodologies necessary to assist every legal cannabis operation with each aspect of the business from facility design & construction, cultivation & production, to marketing, branding, wholesale, retail, and patient care.

CNAB is established both domestically and internationally via its consulting services, management and oversight making them capable of assisting any Cannabis oriented company on any scale.

Lucrative agreements already in place. The Company recently announced that it has signed separate management, marketing and distribution agreements with The Melts and Emotek. United Cannabis will market Melts' and Emoteks' products on an exclusive basis to the Company's retail contacts, including licensed medical centers, dispensaries, pharmacies, alternative healing centers, hospitals, retail centers and wholesale outlets.

Stout Management Team: Earnest Blackmon, president and CEO, is a horticulturalist and entrepreneur with over 20 years' experience, including 5 years in the Commercial Cannabis Industry. Mr. Blackmon is also an owner and the master grower at River Rock Colorado in addition to his duties at United Cannabis. Mr. Blackmon has developed a proprietary grow method based on an organic standard to aid in stable chemical synthesis to limit side reactions that diminish yield. Mr. Blackmon's skill with operations, project management, quality control and cultivation ensure that every United Cannabis sponsored production facility will produce consistent high-grade organic cannabis to meet the demands of its patients.

Significant barriers to entry for those unable to navigate the new highly regulated regime.

GW Pharmaceutical set the standard, and there are no direct competitors in the United States.
CNAB Chart


Market Value:
78,053,000 a/o Jan 15, 2015

Shares Outstanding:
43,850,000 a/o Nov 19, 2014

3,275,000 a/o May 22, 2014

Authorized Shares:

100,000,000 a/o Mar 31, 2013

Par Value:

Short Interest
75,223 (23.77%) Dec 15, 2014

Transfer Agent:
Direct Transfer, LLC.


United Cannabis Corporation Signs Licensing Agreement for California with Foxbarry Farms Tribal Development Group

United Cannabis Corp. Partners Behind 14 Top Prizes in November's Leading Cannabis Competitions

United Cannabis Corporation Subsidiary Awarded Provisional Cultivation and Production Licenses In Nevada


Ernie Blackmon President


Chad Ruby

Tony Verzura
Senior VP

Paul Enright
VP, Bus. Dev. & Corp. Rel.

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks